Literature DB >> 19755042

NCCN task force report: management of neuropathy in cancer.

Michael D Stubblefield, Harold J Burstein, Allen W Burton, Christian M Custodio, Gary E Deng, Maria Ho, Larry Junck, G Stephen Morris, Judith A Paice, Sudhakar Tummala, Jamie H Von Roenn.   

Abstract

Neuropathy is a common, often debilitating complication of cancer and its treatment. Effective management of this disorder depends on early diagnosis and an understanding of its underlying causes in the individual patient. In January 2009, NCCN gathered a multidisciplinary group to review the literature and discuss intervention strategies currently available to patients as well as areas that require research efforts. The task force, which comprised experts in anesthesiology, medical oncology, neurology, neuro-oncology, neurophysiology, nursing, pain management, and rehabilitation, was charged with the goal of outlining recommendations for the possible prevention, diagnosis, and management of neuropathy. This report documents the proceedings of this meeting with a general background on neuropathy and neuropathy in oncology, followed by discussions on challenges and research issues, evaluation criteria, and management of different symptoms associated with this disorder.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19755042     DOI: 10.6004/jnccn.2009.0078

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


  50 in total

1.  Physical Rehabilitation Practices for Children and Adolescents with Cancer in Canada.

Authors:  Paula A Ospina; Lesley Wiart; David D Eisenstat; Margaret L McNeely
Journal:  Physiother Can       Date:  2020       Impact factor: 1.037

2.  Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire.

Authors:  Ellen M Lavoie Smith; Debra L Barton; Rui Qin; Preston D Steen; Neil K Aaronson; Charles L Loprinzi
Journal:  Qual Life Res       Date:  2013-03-30       Impact factor: 4.147

3.  The prevalence and pattern of chemotherapy-induced peripheral neuropathy among women with breast cancer receiving care in a large community oncology practice.

Authors:  Natalie B Simon; Michael A Danso; Thomas A Alberico; Ethan Basch; Antonia V Bennett
Journal:  Qual Life Res       Date:  2017-06-29       Impact factor: 4.147

Review 4.  Current use of drugs affecting the central nervous system for chemotherapy-induced peripheral neuropathy in cancer patients: a systematic review.

Authors:  Sang Hui Chu; Young Joo Lee; Eon Sook Lee; Yimin Geng; Xin Shelley Wang; Charles S Cleeland
Journal:  Support Care Cancer       Date:  2014-09-26       Impact factor: 3.603

Review 5.  Opportunities for rehabilitation of patients with radiation fibrosis syndrome.

Authors:  Katarzyna Hojan; Piotr Milecki
Journal:  Rep Pract Oncol Radiother       Date:  2013-08-08

Review 6.  A Focused Review of Safety Considerations in Cancer Rehabilitation.

Authors:  Susan Maltser; Adrian Cristian; Julie K Silver; G Stephen Morris; Nicole L Stout
Journal:  PM R       Date:  2017-09       Impact factor: 2.298

7.  Radiation Fibrosis Syndrome Imitating Breast Cancer Recurrence; A Case Report.

Authors:  Dauren Sarsenov; Fatma Aktepe; Vahit Özmen
Journal:  J Breast Health       Date:  2017-01-01

8.  Incidence of chemotherapy-induced peripheral neuropathy within 12 weeks of starting neurotoxic chemotherapy for multiple myeloma or lymphoma: a prospective, single-center, observational study.

Authors:  Veronica B Ajewole; James E Cox; Joshua T Swan; Soumya G Chikermane; Beverly Lamoth; Tomona Iso; Laura O Okolo; Christen L Ford; Amy M Schneider; Eleanor C Hobaugh; Kelty R Baker
Journal:  Support Care Cancer       Date:  2019-07-29       Impact factor: 3.603

Review 9.  Exercise intervention studies in patients with peripheral neuropathy: a systematic review.

Authors:  Fiona Streckmann; Eva M Zopf; Helmar C Lehmann; Kathrin May; Julia Rizza; Philipp Zimmer; Albert Gollhofer; Wilhelm Bloch; Freerk T Baumann
Journal:  Sports Med       Date:  2014-09       Impact factor: 11.136

10.  Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial.

Authors:  Ellen M Lavoie Smith; Herbert Pang; Constance Cirrincione; Stewart Fleishman; Electra D Paskett; Tim Ahles; Linda R Bressler; Camilo E Fadul; Chetaye Knox; Nguyet Le-Lindqwister; Paul B Gilman; Charles L Shapiro
Journal:  JAMA       Date:  2013-04-03       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.